Insufficient Apaf-1 expression in early stages of neural differentiation of human embryonic stem cells might protect them from apoptosis

• Published in: European journal of cell biology Vol. 97; no. 2; pp. 126 - 135
• Main Authors: Karimzadeh, Somayeh, Hosseinkhani, Saman, Fathi, Ali, Ataei, Farangis, Baharvand, Hossein
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.03.2018
• Subjects: Apaf-1; Apoptosis - physiology; Apoptotic Protease-Activating Factor 1 - metabolism; Cell Differentiation - physiology; Cytochromes c - metabolism; Human embryonic stem cell; Human Embryonic Stem Cells - cytology; Human Embryonic Stem Cells - metabolism; Humans; Mitochondria - metabolism; Mitochondrial apoptosis; Neural differentiation; Reactive Oxygen Species - metabolism; Signal Transduction; Tumor Suppressor Protein p53 - metabolism; Human embryonic stem cell; Mitochondrial apoptosis; Apaf-1; Neural differentiation
• ISSN: 0171-9335; 1618-1298
• DOI: 10.1016/j.ejcb.2018.01.005

Recent evidence suggests that mitochondrial apoptosis regulators and executioners may regulate differentiation, without being involved in cell death. However, the involved factors and their roles in differentiation and apoptosis are still not fully determined. In the present study, we compared mitochondrial pathway of cell death during early neural differentiation from human embryonic stem cells (hESCs). Our results demonstrated that ROS generation, cytosolic cytochrome c release, caspases activation and rise in p53 protein level occurred upon either neural or apoptosis induction in hESCs. However, unlike apoptosis, no remarkable increase in apoptotic protease activating factor-1 (Apaf-1) level at early stages of differentiation was observed. Also the caspase-like activity of caspase-9 and caspase-3/7 were seen less than apoptosis. The results suggest that low levels of Apaf-1 as an adaptor protein might be considered as a possible regulatory barrier by which differentiating cells control cell death upon rise in ROS production and cytochrome c release from mitochondria. Better understanding of mechanisms via which mitochondria-mediated apoptotic pathway promote neural differentiation can result in development of novel therapeutic approaches.